Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer. Cortes J, Kim SB, Chung WP, Im SA, et al. N Engl J Med 2022;386:1143-1154.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cortes J, Kim SB, Chung WP, Im SA, et al. Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer. N Engl J Med 2022;386:1143-1154.
PMID: 35320644